Introducing Population Pharmacokinetic Analysis Into Your Early Drug Development Efforts
Pharmaceutics | Free Full-Text | Matrix Effects of the Hydroethanolic Extract of Calyces of Physalis peruviana L. on Rutin Pharmacokinetics in Wistar Rats Using Population Modeling
Pharmacokinetic Modeling Software - an overview | ScienceDirect Topics
Simulation results using PK parameters obtained from PopPK analysis... | Download Scientific Diagram
Using Pop PK Modeling to Optimize Dosing in Patients with Organ Impairment - YouTube
Analysis of pk data- Pop PK analysis
Population PK/PD analysis: what, why, how and when - Insights From Our Labs to Yours
Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics - Lu - 2017 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
Clinical applications of population pharmacokinetic models of antibiotics: Challenges and perspectives - ScienceDirect
A Survey of Population Pharmacokinetic Reports Submitted to the USFDA: An Analysis of Common Issues in NDA and BLA from 2012 to 2021 | SpringerLink
Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies | British Journal of Cancer
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study | Thrombosis Journal | Full Text
Pharmacokinetics and population pharmacokinetics in pediatric oncology - Sassen - 2020 - Pediatric Blood & Cancer - Wiley Online Library
Introducing Population Pharmacokinetic Analysis Into Your Early Drug Development Efforts
Frontiers | Individualized Dosing With High Inter-Occasion Variability Is Correctly Handled With Model-Informed Precision Dosing—Using Rifampicin as an Example
Role of pharmacokinetic modeling and simulation in precision dosing of anticancer drugs
A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism | Journal of Pharmacology and Experimental Therapeutics
POPULATION PK — Tasso, Inc.
Establishing Best Practices and Guidance in Population Modeling: An Experience With an Internal Population Pharmacokinetic Analysis Guidance - Byon - 2013 - CPT: Pharmacometrics & Systems Pharmacology - Wiley Online Library
Population Pharmacokinetic Variables: THETA, ETA, EPSILON; and NONMEM for analysis - Pharmacoengineering
Population pharmacokinetics and dose optimization of vancomycin in neonates | Scientific Reports
Population pharmacokinetic model of cefazolin in total hip arthroplasty | Scientific Reports
Population PK/PD analysis: what, why, how and when - Insights From Our Labs to Yours
Population pharmacokinetics and exposure-response analysis of sotrovimab in the early treatment of COVID-19 | medRxiv
Pharmaceuticals | Free Full-Text | Population Pharmacokinetic Method to Predict Within-Subject Variability Using Single-Period Clinical Data
